ClinicalTrials.gov
ClinicalTrials.gov Menu

ALT-801-activated Natural Killer Cells After FLAG Induction for Acute Myeloid Leukemia

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01478074
Recruitment Status : Withdrawn (The treatment planned was determined to be of low feasibility as no subject was found eligible and able to enroll after screening over 30 subjects)
First Posted : November 23, 2011
Last Update Posted : January 3, 2014
Sponsor:
Collaborator:
M.D. Anderson Cancer Center
Information provided by (Responsible Party):
Altor BioScience

No Study Results Posted on ClinicalTrials.gov for this Study
Study was withdrawn before participants were enrolled.
  Recruitment Status : Withdrawn
  Estimated Primary Completion Date : October 2013
  Actual Study Completion Date : November 2013